PubMed ID: 36727334 Author(s): Das S, Varshney A. Commentary: Can machine be taught to detect retinoblastoma? Indian J Ophthalmol. 2023 Feb;71(2):432-433. doi: 10.4103/ijo.IJO_2283_22. No abstract available. PMID 36727334 Journal: Indian Journal Of Ophthalmology, Volume 71, …
All Posts
UW’s Low Vision Rehabilitation Offers Comprehensive Services to Patients
The National Eye Institute recognizes February as Low Vision Awareness Month. This places a spotlight on vision-related disabilities and the supportive infrastructure needed.
Cytochrome P450 1B1 Expression Regulates Intracellular Iron Levels and Oxidative Stress in the Retinal Endothelium.
PubMed ID: 36768740 Author(s): Song YS, Zaitoun IS, Wang S, Darjatmoko SR, Sorenson CM, Sheibani N. Cytochrome P450 1B1 Expression Regulates Intracellular Iron Levels and Oxidative Stress in the Retinal Endothelium. Int J Mol Sci. …
SANDCAT
A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of RO7200220 Administered Intravitreally in Patients with Uveitic Macular Edema (Sandcat)
CapriCORN
Comprehensive Analysis of Pathogens, Resistomes, and Inflammatory-markers in the Cornea
RECORDATI MT8
Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops (MT8) for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients
IMVT TED
A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)
Remembering Dr. Alice McPherson
With great sadness, the University of Wisconsin-Madison Department of Ophthalmology and Visual Sciences mourns the passing of notable alumna, retina specialist, and vision research advocate Alice McPherson, MD on January 16th, 2023.
New Nanoparticles Deliver Therapy Brain-Wide, Edit Alzheimer’s Gene In Mice
Researchers at UW–Madison have engineered silicone nanoparticles to cross the blood-brain barrier in mice to deliver brain-wide gene editing therapy for Alzheimer’s disease.